SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Sanofi Consumer Healthcare India Ltd (SANOFICONR)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544250 NSE: SANOFICONR Pharmaceuticals & Drugs | Small Cap | Sanofi Cons. Health Share Price

₹4,709.80 -54.80 (-1.15%)

As on 04-Jun'26 16:59

Sanofi Consumer Healthcare India Ltd (SANOFICONR)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544250 NSE: SANOFICONR Pharmaceuticals & Drugs | Small Cap | Sanofi Cons. Health Share Price

₹4,709.80 -54.80 (-1.15%)

As on 04-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹10,847 Cr.
Current Price
₹4,709.8
52-Week Low / High
₹3,951 / 5,954
TTM EPS
₹112
TTM Sales
₹935 Cr.
Book Value per Share
₹196.2
P/E Ratio
42.06
Lower than its 5-year historical median
Industry PE
46.5
Price to Book (P/B)
24.01
Lower than its 5-year historical median
Price to Sales (P/S)
11.60
Lower than its 5-year historical median
EV/EBITDA
29.70
Lower than its 5-year historical median
Dividend Yield
1.12%
Profitability Efficiency
Return on Equity (ROE)
79.28%
Outperforms industry median
Return on Capital Employed (ROCE)
104.33%
Outperforms industry median
Return on Assets (ROA)
40.67%
Operating Profit Margin
37.3%
Net Profit Margin
24.98%
Gross Profit Margin
37%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
30.45%
Operating Profit Growth (1 Year)
-
23.67%
Net Profit Growth (1 Year)
-
9.76%
Asset Quality
Promoter Holding
71.27%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹429 Cr.
Equity
₹23 Cr.
Face Value
₹10
All Time Low / High
₹3950.50 / 5954.00

Sanofi Consumer Healthcare India stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Not Good
Check detailed performance

Valuation

Undervalued

Check Valuation charts

Price Trend

Semi Strong
Check Price chart
Q.1 Is Sanofi Consumer Healthcare India Ltd a good quality company?
Sanofi Consumer Healthcare India Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Sanofi Consumer Healthcare India Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Sanofi Consumer Healthcare India Ltd vs industry peers?
Sanofi Consumer Healthcare India Ltd revenue CAGR is %, compared to the industry median CAGR of 4.57%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Sanofi Consumer Healthcare India Ltd?
Promoters hold 71.27% of the Sanofi Consumer Healthcare India Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Sanofi Consumer Healthcare India Ltd over the last decade?
Over the last 1 year(s), the stock has delivered a CAGR of -6.21% based on the current price.
View More

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Sanofi Consumer Healthcare India Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Dec'23Dec'24TTM
ROCE % ⓘ105.6%104.3%-
Value Creation
Index ⓘ		6.86.7-

Growth Parameters ⓘ
Sales ⓘ555725935
Sales YoY Gr.-30.5%-
Adj EPS ⓘ830.887.2112
YoY Gr.--89.5%-
BVPS (₹) ⓘ923118.3196.2
Adj Net
Profit ⓘ		166201258
Cash Flow from Ops. ⓘ-0.4439-
Debt/CF from Ops. ⓘ00-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNANANA30.5%
Adj EPS ⓘNANANA-89.5%
BVPSⓘNANANA-87.2%
Share Price - - - -7.3%

Key Financial Parameters ⓘ

Dec'23Dec'24TTM
Return on
Equity % ⓘ		8083.671.2
Op. Profit
Mgn % ⓘ		39.437.435.7
Net Profit
Mgn % ⓘ		29.927.727.6
Debt to
Equity ⓘ		00-
Working Cap
Days ⓘ		012682
Cash Conv.
Cycle ⓘ		0-1857

Profit And Loss

(All Figures are in Crores.)
PARTICULARSDec'23Dec'24
Sales555725
Operating Expenses ⓘ + 337454
Manufacturing Costs4345
Material Costs152186
Employee Cost 54103
Other Costs ⓘ 87120
Operating Profit ⓘ 219271
Operating Profit Margin (%) 39.4%37.3%
Other Income ⓘ + 413
Exceptional Items ⓘ -2-28
Interest ⓘ 04
Depreciation ⓘ 25
Profit Before Tax ⓘ 219247
Tax ⓘ 5466
Profit After Tax 165181
PAT Margin (%) 29.7%25.0%
Adjusted EPS (₹)824.578.7
Dividend Payout Ratio (%)6.10%69.90%

Valuation of Sanofi Cons. Health - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSDec'23Dec'24

Equity and Liabilities

Shareholders Fund + 185272
Share Capital ⓘ 223
Reserves ⓘ 183249
Debt +00
Long Term Debt00
Short Term Debt00
Minority Interest00
Trade Payables6070
Others Liabilities ⓘ 99204
Total Liabilities ⓘ 344547

Fixed Assets

Net Fixed Assets ⓘ +529
Gross Block1140
Accumulated Depreciation611
CWIP ⓘ 31
Investments ⓘ 00
Inventories9741
Trade Receivables3214
Cash Equivalents flag ⓘ 2327
Others Assets ⓘ 206135
Total Assets ⓘ 344547

Cash Flow

(All Figures are in Crores.)
PARTICULARSDec'23Dec'24
Cash Flow From Operating Activity ⓘ + -0439
PBT ⓘ 219247
Adjustment ⓘ -21
Changes in Working Capital ⓘ -213316
Tax Paid ⓘ -4-124
Cash Flow From Investing Activity ⓘ + 02
Capex -4-10
Net Investments 00
Others ⓘ 412
Cash Flow From Financing Activity ⓘ + 2-116
Net Proceeds from Shares ⓘ 20
Net Proceeds from Borrowing ⓘ 00
Interest Paid ⓘ 0-0
Dividend Paid ⓘ 0-115
Others ⓘ 00
Net Cash Flow ⓘ 2325

Financial Ratio

PARTICULARSDec'23Dec'24
Ratios
ROE (%)89.3379.28
ROCE (%)105.64104.33
Asset Turnover Ratio1.681.7
PAT to CFO Conversion(x)-02.43
Working Capital Days
Receivable Days2010.90
Inventory Days6133.20
Payable Days144.20127.80

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Sanofi Consumer Healthcare India Ltd FAQs

The current trading price of Sanofi Cons. Health on 04-Jun-2026 16:59 is ₹4,709.8.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Sanofi Cons. Health stood at ₹10,847 Cr

The latest P/E ratio of Sanofi Cons. Health as of 03-Jun-2026 is 42.06.

The latest P/B ratio of Sanofi Cons. Health as of 03-Jun-2026 is 24.01.

The 52-week high of Sanofi Cons. Health is ₹5,954 and the 52-week low is ₹3,950.5.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sanofi Cons. Health is ₹935 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Sanofi Consumer Healthcare India Ltd is a below average quality company.

The key valuation ratios of Sanofi Consumer Healthcare India Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Sanofi Consumer Healthcare India Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Sanofi Consumer Healthcare India Ltd

No data to display
You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×